Sangamo Therapeutics
SGMO
#10548
Rank
S$39.54 M
Marketcap
S$0.09546
Share price
0.00%
Change (1 day)
-81.26%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2026 (TTM): S-$0.49

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$0.49. In 2025 the company made an earnings per share (EPS) of S-$0.57 an increase over its 2024 EPS that were of S-$0.66.

EPS history for Sangamo Therapeutics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.49-14.1%
2025S-$0.57-13.73%
2024S-$0.66
2022S-$1.610.81%
2021S-$1.6033.33%
2020S-$1.206.9%
2019S-$1.1222.54%
2018S-$0.921.43%
2017S-$0.90-31.37%
2016S-$1.3275.86%
2015S-$0.7548.72%
2014S-$0.50-17.02%
2013S-$0.619.3%
2012S-$0.55-39.44%
2011S-$0.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.42-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$3.04-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S-$1.64 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S-$4.00 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.28-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$25.56-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S-$0.12-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA